Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of Nifurtimox, an antitrypanosomiasis drug

Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie
Michael J IatropoulosG M Williams

Abstract

The chronic toxicity and carcinogenicity of Nifurtimox (NFX), a 5-nitrofuran derivative used in the treatment of American trypanosomiasis, were studied in male and female Wistar rats in an accelerated cancer bioassay (ACB). The ACB is a mechanistic initiation/promotion chronic toxicity and carcinogenicity bioassay designed to assess potential carcinogenic activity of a test substance in critical organs and tissues of rodents in which human carcinogens are active. The organs studied were liver, lungs, urinary bladder (UB), mammary gland (MG), bone marrow, spleen, kidneys, colon, stomach and any grossly observed lesions. NFX is a genotoxin which has been reported previously to exert a variable degree of carcinogenic activity in rat liver, kidney, UB and MG. The present study was undertaken to assess whether NFX has initiating activity in these four named target sites. In the initiation phase, groups of 20 Wistar rats were given NFX daily in the diet at 0.2% for the first 12 weeks of the study to assess initiating activity, followed by promoters (PROs) for four organs for an additional 24 weeks. NFX was compared to the following known initiators (INs) for each of these four tissues: diethylnitrosamine (DEN) for liver and kidney, N...Continue Reading

References

Jan 1, 1978·Transactions of the Royal Society of Tropical Medicine and Hygiene·A PatruccoE L Segura
Dec 1, 1992·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·G M Williams
Dec 1, 1992·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·M J Iatropoulos
Feb 1, 1990·Experimental and Molecular Pathology·C R de CastroJ A Castro
May 1, 1987·Mutation Research·R Nagel
Mar 1, 1980·Mutation Research·T OhnishiS Inoki
Mar 1, 1994·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·E Bomhard, M Rinke
Feb 1, 1996·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·G M WilliamsJ H Weisburger
Aug 1, 1997·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·M J IatropoulosA P Leber
Jun 1, 1994·Environmental Health Perspectives·H VainioJ Wilbourn
Jan 31, 2002·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·M J IatropoulosG M Williams
Mar 1, 1964·Biochemical Pharmacology·J H CUTTS
Aug 30, 2006·Human & Experimental Toxicology·José A CastroLaura C Bartel
Sep 9, 2009·Experimental Parasitology·Rodrigo López-MuñozJuan D Maya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie
Michael J IatropoulosG M Williams
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie
Michael J IatropoulosA P Leber
Trends in Parasitology
Simon L CroftJulio A Urbina
Nature Chemical Biology
Adam R Renslo, James H McKerrow
© 2022 Meta ULC. All rights reserved